Fokale Therapie des Prostatakarzinoms in Deutschland – Status 2014-Reference-Cited by-同舟云学术

Fokale Therapie des Prostatakarzinoms in Deutschland – Status 2014

Published:2014-06-20 Issue:7 Volume:53 Page:1040-1045
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Roosen A., ,Ganzer R.,Hadaschik B.,Köllermann J.,Blana A.,Henkel T.,Liehr A.-B.,Baumunk D.,Machtens S.,Salomon G.,Sentker L.,Witsch U.,Köhrmann K.U.,Schostak M.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-014-3532-2.pdf

Reference29 articles.

1. Baumunk D, Blana A, Ganzer R et al (2013) Focal prostate cancer therapy: capabilities, limitations and prospects. Urologe A 52(4):549–556

2. Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228–1242

3. Jeldres C, Suardi N, Walz J et al (2008) Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men. Eur Urol 54:1306–1313

4. Budäus L, Graefen M, Salomon G et al (2010) The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy. Int J Urol 17:862–868

5. Xylinas E, Durand X, Campeggi A et al (2011) Pathological findings after radical prostatectomy in men eligible for active surveillance (French trial SURACAP): is the misclassification rate acceptable? Prog Urol 21:264–269

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fokale Therapie des Prostatakarzinoms in Deutschland;Der Urologe;2016-05

2. Irreversible Elektroporation;Der Urologe;2015-05-31

3. Therapie des lokalisierten Prostatakarzinoms mit hochintensivem fokussierten Ultraschall;Der Urologe;2015-01-16

4. p53 family members – important messengers in cell death signaling in photodynamic therapy of cancer?;Photochemical & Photobiological Sciences;2015